Received Jun 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | LA |
Headache; Not feeling well; This non-serious case was reported by a consumer via call center representative and described the occurrence of unwell in a 68-year-old female patient who received Herpes zoster (Shingrix) for shingles prevention. On 25-MAY-2026, the patient received the 2nd dose of Shingrix (left deltoid). On 25-MAY-2026, less than a day after receiving Shingrix, the patient experienced unwell (Verbatim: Not feeling well). On 26-MAY-2026, the patient experienced headache (Verbatim: Headache). The outcome of the unwell was unknown and the outcome of the headache was not resolved. It was unknown if the reporter considered the unwell and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 26-MAY-2026 The reporter was the husband who called on behalf of his wife, a female patient. The reporter reported that the patient was not feeling well last night. The reporter further stated that on the morning of 26-MAY-2026, the patient had a splitting headache and was still in bed at 10 AM local time, which was not typical behavior for the patient. The batch number was not provided upon follow-up with the reporter.